Dynavax Technologies | Marknadsvärde



Market Capitalization Ändra Datum
AbbVie USD 314.02B 34.8B 2024-12
Adma Biologics USD 4.06B 667M 2024-12
Amgen USD 139.96B 33.39B 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
Biogen USD 22.28B 5.95B 2024-12
BioMarin Pharmaceutical USD 12.54B 855M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Dynavax Technologies USD 1.68B 219M 2024-12
Gilead Sciences USD 115.09B 10.63B 2024-12
Merck USD 251.65B 36.21B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Sarepta Therapeutics USD 11.78B 128M 2024-12
TG Therapeutics USD 4.69B 1.07B 2024-12
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Dynavax Technologies Marknadsvärde - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.